Pharma Journalist -

MEBIAS Discovery, an emerging leader in the field of drug discovery targeting G-protein coupled receptors, has secured grant funding from the National Institute of Drug Abuse (NIDA) to…
Read More...

Celltrion, Inc. signed an ‘Incubation’ agreement with Emory University in Atlanta to support the research and development of new drug candidates for atherosclerosis. ‘Incubation’…
Read More...

AGC Biologics announced that as part of its ongoing program to expand its production capacities globally, it will establish a new state of the art process development and manufacturing…
Read More...

PharmaBlock Sciences recently announced the appointment of Dr. Shijie Zhang as Chief Technology Officer. Shijie joins the company from Agios Pharmaceuticals, Inc., where he was Director…
Read More...

Seattle Genetics announced that its collaborator, Takeda Pharmaceutical Company Limited (Takeda), has received approval from the Japanese Ministry of Health, Labour and Welfare for…
Read More...

BIA Separations announced the expansion of its services with the opening of a new upstream processing (USP) laboratory. The investment in the new facility comes in response to…
Read More...

Neurimmune announced the achievement of a key preclinical milestone in the ongoing collaboration with Ono Pharmaceutical Co., Ltd. In November 2017, the parties entered into a…
Read More...

Lonza announces the addition of two new Ibex Solutions offerings to Lonza's 100,000 m2 (1.1 million ft2) biopark in Visp (CH). In July 2017 Ibex Dedicate, a modular, technology-agnostic…
Read More...

Thermo Fisher Scientific announced its intent to open multiple Global Customer Solution Centers. The new Global Customer Solution Centers will focus on meeting and exceeding the demands…
Read More...

Emergex Vaccines Holding Limited announces that it has signed a Memorandum of Understanding (MoU) with Brazil-based Oswaldo Cruz Foundation ‘Fiocruz’ for the development of viral…
Read More...